The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer

Seminars in Oncology

Volumn 38, Issue 1, 2011, Pages 16-25

  Yankeelov, Thomas E ^a,b,c   Arlinghaus, Lori R ^a   Li, Xia ^a   Gore, John C ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GADOLINIUM; PHARMACOLOGICAL BIOMARKER;

ACCURACY; ADJUVANT THERAPY; ARTICLE; BREAST CANCER; CANCER THERAPY; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYTOTOXICITY; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; GLIOBLASTOMA; HUMAN; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY; SOLID TUMOR; STANDARD; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; DIFFUSION MAGNETIC RESONANCE IMAGING; DRUG MONITORING; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; NEOPLASMS;

EID: 79952143494     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2010.11.007     Document Type: Article

References (39)

1. T.E. Yankeelov, M.J. Avison, B.M. Damon, H.C. Manning, T.E. Peterson, and J.C. Gore Frontiers of Biomedical Imaging Science 2009: workshop report and research opportunities Cancer Res 69 2009 7902 7904
2. P. Therasse, S.G. Arbuck, E.A. Eisenhauer European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216 (Pubitemid 30099779)
3. A. Einstein ber die von der molekularkinetischen Theorie der Wrme geforderte Bewegung von in ruhenden Flüssigkeiten suspendierten Teilchen Annalen der Physik 322 1905 549 560
4. A.W. Anderson, J. Xie, J. Pizzonia, R.A. Bronen, D.D. Spencer, and J.C. Gore Effects of cell volume fraction changes on apparent diffusion in human cells Magn Reson Imaging 18 2000 689 695 (Pubitemid 30626358)
5. P. Hagmann, L. Jonasson, P. Maeder, J.P. Thiran, V.J. Wedeen, and R. Meuli Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond Radiographics 26 2006 S205 S223
6. E.M. Charles-Edwards, and N.M. deSouza Diffusion-weighted magnetic resonance imaging and its application to cancer Cancer Imaging 6 2006 135 143
7. F.G. Shellock, and E. Kanal Safety of magnetic resonance imaging contrast agents J Magn Reson Imaging 10 1999 477 484 (Pubitemid 29463135)
8. T.E. Yankeelov, and J.C. Gore Dynamic contrast-enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples Curr Med Imaging Rev 3 2007 91 107 (Pubitemid 46773870)
9. W.B. Pope, H.J. Kim, and J. Huo Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment Radiology 252 2009 182 189
10. D.A. Hamstra, T.L. Chenevert, and B.A. Moffat Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma Proc Natl Acad Sci U S A 102 2005 16759 16764 (Pubitemid 41688850)
11. D.A. Hamstra, C.J. Galbn, and C.R. Meyer Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival J Clin Oncol 26 2008 3387 3394
12. U. Sharma, K.K.A. Danishad, V. Seenu, and N.R. Jagannathan Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy NMR Biomed 22 2009 104 113
13. M.L. Ah-See, A. Makris, and N.J. Taylor Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer Clin Cancer Res 14 2008 6580 6589
14. R. Johansen, L.R. Jensen, and J. Rydland Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI J Magn Reson Imaging 29 2009 1300 1307
15. W.R. Jarnagin, L.H. Schwartz, and D.H. Gultekin Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival Ann Oncol 20 2009 1589 1595
16. C. Hutton, A. Bork, O. Josephs, R. Deichmann, J. Ashburner, and R. Turner Image distortion correction in fMRI: A quantitative evaluation Neuroimage 16 2002 217 240 (Pubitemid 34852485)
17. Y. Bito, S. Hirata, and E. Yamamoto Optimum gradient factors for apparent diffusion coefficient measurements Proc Intl Soc Magn Reson Med 3 1995 913
18. H.L. Cheng Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI J Magn Reson Imaging 28 2008 736 743
19. A.L. Martel, R.W. Chan, E. Ramsay, and D.B. Plewes Removing undersampling artifacts in DCE-MRI studies using independent components analysis Magn Reson Med 59 2008 874 884 (Pubitemid 351501954)
20. W. Huang, Y. Wang, D.M. Panicek, L.H. Schwartz, and J.A. Koutcher Feasibility of using limited-population-based average R10 for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced magnetic resonance imaging data Magn Reson Imaging 27 2009 852 858
21. H.J. Weinmann, M. Laniado, and W. Mutzel Pharmacokinetics of GdDTPA/Dimeglumine after intravenous injection into healthy volunteers Physiol Chem Phys Med NMR 16 1984 167 172
22. C. Yang, G.S. Karczmar, M. Medved, and W.M. Stadler Multiple reference tissue method for contrast agent arterial input function estimation Magn Reson Med 58 2007 1266 1275 (Pubitemid 350234214)
23. T.E. Yankeelov, J.J. Luci, L.M. DeBusk, P.C. Lin, and J.C. Gore Incorporating the effects of transcytolemmal water exchange in a reference region model for DCE-MRI analysis: theory, simulations, and experimental results Magn Reson Med 59 2008 326 335 (Pubitemid 351220096)
24. C.R. Planey, E.B. Welch, and L. Xu Temporal sampling requirements for reference region modeling DCE-MRI data in human breast cancer analysis J Magn Reson Imaging 30 2009 121 134
25. C. Yang, G.S. Karczmar, M. Medved, A. Oto, M. Zamora, and W.M. Stadler Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast-enhanced-MRI analysis Magn Reson Med 61 2009 851 859
26. T.E. Yankeelov, L.M. DeBusk, and D.D. Billheimer Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T J Magn Reson Imaging 24 2006 1140 1147 (Pubitemid 44658253)
27. W. Huang, X. Li, and E.A. Morris The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo Proc Natl Acad Sci U S A 105 2008 17943 17948
28. D.L. Buckley, L.E. Kershaw, and G.J. Stanisz Cellular-interstitial water exchange and its effect on the determination of contrast agent concentration in vivo: dynamic contrast-enhanced MRI of human internal obturator muscle Magn Reson Med 60 2008 1011 1019
29. B. Ma, C.R. Meyer, and M.D. Pickles Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment Inf Process Med Imaging 21 2009 276 287
30. X. Li, B.M. Dawant, and E.B. Welch A nonrigid registration algorithm for longitudinal breast MR images and the analysis of breast tumor response Magn Reson Imaging 27 2009 1258 1270
31. P. Gibbs, M.D. Pickles, and L.W. Turnbull Repeatability of echo-planar-based diffusion measurements of the human prostate at 3 T Magn Reson Imaging 25 2007 1423 1429 (Pubitemid 350122914)
32. D.M. Koh, M. Blackledge, and D.J. Collins Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial Eur Radiol 19 2009 2728 2738
33. M.J. Paldino, D. Barboriak, A. Desjardins, H.S. Friedman, and J.J. Vredenburgh Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiforme J Magn Reson Imaging 2009 1199 1205
34. S.M. Galbraith, M.A. Lodge, and N.J. Taylor Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis NMR Biomed 15 2002 132 142 (Pubitemid 34213403)
35. C.S. Ng, D.L. Raunig, and E.F. Jackson Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses Am J Roentgenol 194 2010 W134 W140
36. E. Ashton, D. Raunig, C. Ng, F. Kelcz, T. McShane, and J. Evelhoch Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions J Magn Reson Imaging 28 2008 791 796
37. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
38. A.R. Padhani, G. Liu, and D.M. Koh Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2009 102 125
39. J. Evelhoch, M. Garwood, and D. Vigneron Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report Cancer Res 65 2005 7041 7044 (Pubitemid 41161229)